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This study aimed to investigate the relationship between socioeconomic inequality and mortality fol-
lowing the introduction of a public mammography screening program in Norway by exploring the role of
change in stage distribution as the mechanism for differences before and after the introduction of the
screening program. Attained education level was used as a measure of socioeconomic status in this
population-based study. All women aged 50–69 years diagnosed with breast cancer from 1999–2008 and
with follow-up data until the end of 2009 were included. The primary endpoint was all-cause mortality.
The results of a mediation analysis indicated that the introduction of screening led to stage distribution
related reductions of 5.6 (95% conﬁdence interval ¼ 6.7 to 4.5), 2.5 (3.0 to 2.1), and 1.4
(1.9 to 0.9) fewer deaths per 1000 women for with a primary school education, secondary school
education, and university education, respectively. The study showed that stage distribution explained 5
(5.9 to 4.1) fewer deaths among women with a university education and 2.4 (2.9 to 2.0) fewer
deaths among women with a secondary school education before program implementation when com-
pared to the group with a primary school education. There were signiﬁcant reductions in mortality due
to stage distribution after program implementation with differences relative to women with primary
school of 1.8 (2.2 to 1.4) and 0.7 (0.9 to 0.5) fewer deaths in favor of women with university
education and secondary school, respectively. The results indicate reduced importance of cancer stage as
a reason for differences in mortality by socioeconomic status after the introduction of a public mam-
mography program.
& 2016 The Author. Published by Elsevier Ltd. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Despite the interest and controversy regarding the effects of
breast cancer screening programs, little is known about subsequent
changes related to socioeconomic inequality in mortality. Different
research groups (Kalager et al., 2009; Kalager, Zelen, Langmark, &
Adami, 2010; Olsen et al., 2012) have investigated the introduction
of public screening in Norway; however, their principal aims were to
examine the overall impacts of the program on mortality and not to
describe change according to interactions with sociodemographic
characteristics. Previously published studies on breast cancer and
socioeconomic status (SES) have emphasized the relationship be-
tween the incidence of cancer, patient mortality, and breast cancer
mortality in the general population. However, while the incidence of
breast cancer and breast cancer mortality among the general po-
pulation has been shown to concentrate among women with a
higher SES (Braaten, Weiderpass, Kumle, & Lund, 2005; Menvielletd. This is an open access article u
NO-0317 Oslo, Norway.et al., 2011; Pudrovska, Carr, McFarland, & Collins, 2013; Robsahm &
Tretli, 2005; Strand et al., 2007; Strand, Tverdal, Claussen, & Zahl,
2005), this is not so for breast cancer mortality among patients.
Among patients diagnosed with breast cancer, a poor prognosis
is more frequent among women with a lower SES (Byers et al.,
2008; Halmin et al., 2008; Kravdal, 2000; Louwman, van de Poll-
Franse, Fracheboud, Roukema, & Coebergh, 2007), and this re-
lationship has been shown to relate to differences in cancer stage
at diagnosis. Indeed, this is a ﬁnding common among a wide array
of cancer types (Lyratzopoulos et al., 2012; Woods, Rachet, & Co-
leman, 2006). In Norway, Kravdal (2000) used pre-screening
program data from 1960 to 1991 to document the importance of
SES (focusing on attained education) for mortality among cancer
patients in general. Furthermore, for breast cancer, Kravdal found
that differences in stage distribution had a mediating role, ex-
plaining a quarter of differences between education levels. Link,
Northridge, Phelan, and Ganz (1998) discussed education as an
important marker of SES in the context of breast cancer since a
given education leads to particular working careers and associated
incomes as well as knowledge and interpersonal power.nder the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Table 1
Date of the NBCSPa introduction in Norwegian counties.
County Date of
introduction
Data collection period re-
lative to introduction
Rogaland November 20, 1995 3.1–13.1 years after
Oslo January 8, 1996 3.0–12.9 years after
Hordaland January 15, 1996 3.0–12.9 years after
Akershus February 12, 1996 2.9–12.9 years after
Telemark September 13,
1999
0.8 to 9.3 years after
(1) Aust-Agder and November 1, 1999 0.8 to 9.1 years after
S.T. Klitkou / SSM -Population Health 2 (2016) 502–511 503In the setting of screening, Yabroff and Gordis (2003) in-
vestigated the relationship between breast cancer incidence, sur-
vival, and mortality. Yabroff and Gordis stressed that the relative
importance of these aspects on the overall association between
SES and breast cancer mortality depends on the stage distribution
of new cases and the relation of stage distribution with SES as well
as the strength of the relationship between SES and survival, all
aspects that are susceptible to change under new cancer control
programs. These authors further mentioned that other factors,
such as adjuvant therapy, may also differ by SES.
In Norwegian counties, organized mammography screening for
breast cancer was introduced in phases starting in 1995/1996 and
again in 2004. Following the objectives of the Norwegian Breast
Cancer Screening Program (NBCSP), screening was introduced to
reduce breast cancer mortality through earlier detection (Cancer
Registry of Norway, 2000). It should be noted that, in Norway,
higher education in public institutions is tuition-free, and uni-
versal access to health care is provided within a single-payer
public system.
Any mammography screening conducted prior to the in-
troduction of the public program in Norway has been referred to
as a setting of opportunistic screening. This describes a situation
where the general practitioner or social network promoted, or the
women themselves pursued, unsystematic mammography
screening at some, often irregular, interval (Hofvind, Vacek, Skelly,
Weaver, & Geller, 2008; Lynge et al., 2011). Lynge et al. estimated
that some 40% of Norwegian women had a mammography ex-
amination prior to introduction of the program. However, with the
introduction of organized screening in Norway, every female aged
50–69 was invited to be screened every 2 years resulting in an
overall participation rate of 77% (Giordano et al., 2012).
In addition, Link et al. (1998) point to the dynamics of changing
inequalities, whereby higher SES groups are more adept to make
use of technologies when introduced. Link et al. also discussed the
diverging inequalities concerning mammography screening in an
opportunistic screening setting. From a technology diffusion point
of view, these authors did not comment on whether population-
based screening programs could contribute to narrowing the gap
in inequalities.
Against this background, the aims of this article are twofold.
The ﬁrst aim is to explore changes in patient mortality rates as-
sociated with changes in cancer stage at the introduction of the
screening program for each level of education (the within-educa-
tion group changes). The second aim is to describe changes to the
marginal importance of cancer stage for differences by education
level before and after the introduction of the screening program
(the between-education group differences). Motivated by the
discussion of Yabroff and Gordis (2003), a small sensitivity analysis
was conducted to determine the plausibility of the results. Thus,
education-speciﬁc changes in the incidence of breast cancer at the
introduction of the program were investigated and the results on
mortality were compared after adjusting for the association be-
tween education and the risk of dying from causes other than
breast cancer.(2) Vest-Agder
(1) Troms and (2) Finnmark May 22, 2000 1.3 to 8.5 years after
Østfold April 17, 2001 2.3 to 7.7 years after
Nordland May 17, 2001 2.4 to 7.6 years after
Buskerud September 10,
2001
2.7 to 7.3 years after
(1) North and (2) South
Trøndelag
September 17,
2001
2.7 to 7.3 years after
Oppland January 15, 2002 3.0 to 6.9 years after
Møre og Romsdal April 14, 2002 3.3 to 7.6 years after
Sogn og Fjordane February 13, 2003 4.1 to 5.9 years after
Hedmark August 25, 2003 4.6 to 5.3 years after
Vestfold February 2, 2004 5.1 to 4.9 years after
a NBCSP: Norwegian Breast Cancer Screening Program.2. Methods and setting
The data from all Norwegian women aged 50–69 who were
diagnosed with breast cancer between 1999 and 2008 were col-
lected for this study. Patients were followed until death (from any
cause) or latest date of follow-up as of December 31, 2009 (max-
imum follow-up of 11 years). The death from any cause approach
may be regarded as conservative, since this includes deaths that
are possibly unrelated to breast cancer (Cuzick, 2008). During the
sample period, 15 out of 19 counties in Norway implemented theprogram; 4 counties had already implemented the program in
1995/1996. The county speciﬁc implementation sequence and the
period of data collection can be seen in Table 1. The introduction
was not randomized and took place according to administrative
considerations. The patients were analyzed according to the
county in which they lived in the year when diagnosed with breast
cancer. Information from the cancer registry, which is 99.95%
complete for female breast cancer patients in Norway (Larsen
et al., 2009), was linked with information on SES as well as time
and cause of death from Statistics Norway.
Attained education level was used as a proxy for SES and was
grouped according to primary school (6–9 years of schooling),
secondary school (10–12 years of schooling), and university edu-
cation. Out of a total of 15,862 women, 149 had missing data
concerning education level and 92 had missing data concerning
cancer stage and were excluded from the analysis leaving data for
15,622 women for analysis. Cancer stage was categorized accord-
ing to tumor, node, and metastasis (TNM) staging as follows:
ductal carcinoma in situ (DCIS), TNM I, TNM II, TNM III/IV.
The applied regression models sought to separate the differ-
ences in mortality due to stage distribution from the differences in
mortality due to screening introduction and education. A media-
tion analysis was appropriate for this setting because it captures
the net and gross differences in mortality as a function of exposure
variables—screening introduction (via time period) and education
—and a mediator (cancer stage). The part of the analysis with time
period as the exposure analyzes the within-education group
changes, while the part of the analysis with education as the ex-
posure analyzes the between-education group differences (ela-
borated below). Thus, the analysis considered the joint exposure of
screening introduction and education, of which the screening
program is the exposure that was intervened upon. Primary in-
terest lies with the indirect effects (those through cancer stage),
whereas the direct effects of the exposures then consider differ-
ences other than through this mediator.
All analyses were adjusted for age at diagnosis, year of diag-
nosis, civil status, and parity. Civil status and parity were included
because both variables reﬂect additional resources within the
household, and parity has been found to be related to breast
cancer incidence, survival, and SES (Lappegård et al., 2005; Men-
vielle et al., 2011). Year of diagnosis was included to capture
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iod. The continuous variables age at diagnosis and year of diag-
nosis were entered linearly. Nulliparity was entered as a binary
variable. Civil status was entered as a categorical variable (un-
married, married, widowed, separated/divorced). The introduction
of the NBCSP (time period) was entered as a binary variable to
measure any immediate change as well as a continuous variable
(counting the time since county-speciﬁc introduction) to capture
linear trends in time after introduction reﬂecting the structure of
an interrupted time series analysis (Penfold & Zhang, 2013).
Results are presented according to the two aims of the study,
which separately considers either time period or education level
as the exposure variable. For the analysis of the within-education
group change, estimates of education level speciﬁc changes in
mortality rates mediated by cancer stage were adjusted across
periods. This analysis separated the change in mortality at the
introduction of the screening program for a speciﬁc education
level into (1) a change in general mortality (direct effects) and (2) a
change in mortality due to cancer stage (indirect effects). Thus, for
this part of the analysis time period was analyzed as the exposure
variable and cancer stage as a mediator, separately for each edu-
cation level. While this analysis captures any change to mortality
at screening introduction as direct and indirect effects, it does not
establish the extent of any pre-existing differences between edu-
cation groups due to cancer stage. For the analysis of these be-
tween-education group differences, estimates of mediation by
cancer stage were analyzed with education level as the exposure
variable, introducing an interaction with time period. This then
separated the importance of cancer stage by education level from
general mortality differences between these groups in either time
period, before and after screening introduction.
In the current study mediation was estimated by turning to
natural effect models for direct and indirect effects using a
counterfactual framework and marginal structural models, as
implemented by Lange, Vansteelandt, and Bekaert (2012). As
deﬁned by Nordahl et al. (2014), and taking education as an ex-
ample of the exposure variable, the natural direct effect considers
the difference in mortality between the levels of an exposure
(level of education, say) where the mediator (cancer stage) is that
of the reference education level (primary school). The natural
indirect effect of education on mortality is then represented by
the mortality rate had education been ﬁxed at a given level and
had cancer stage been changed to whatever value cancer stage
would take at that level of education. To implement this deﬁni-
tion of direct and indirect effects in the same analysis, a multi-
nomial logit model for cancer stage was estimated conditioning
on all variables to preserve the model structure in a given ﬁnal
analysis (Lange et al., 2012). Subsequently, a new dataset was
constructed that included an auxiliary variable for the indirect
effect of education on cancer stage, replicating the data one time
for each of the three levels of education. Based on the multi-
nomial logit model, predicted probabilities for each cancer stage
level were obtained, ﬁrst using the original education variable to
represent the direct effect and thereafter using the new auxiliary
education variable to represent the indirect effect. These sets of
predicted probabilities gave the denominator and numerator,
respectively, for the weights of the marginal structural model.
While the above text exempliﬁed the implementation of the
analysis with education as the exposure (i.e. the between-edu-
cation group analysis), a similar interpretation can be given to the
analysis that considers time period as the exposure. However, for
this within-education group analysis the auxiliary variable for
the indirect effects were the replications for each level of time
period, i.e. before and after screening introduction. Across all the
multinomial logit models no weight for any single observationwas exceedingly large, and none of the estimated weights were
beyond 2.5 times larger or smaller than 1. The details of these
estimated models are given in the Appendix separately for the
two main aims of the study (Appendices A and B).
A marginal structural model by means of additive hazard re-
gression was thereafter applied to mortality. Additive hazard re-
gression is a ﬂexible model for survival analyses with the linear
dependence of the model facilitating decomposition into direct,
indirect, and total effects (Lange & Hansen, 2011). The Aalen ad-
ditive hazard regression is, in itself, entirely non-parametric with
covariate effects varying with time (Aalen, 1989). However, a re-
duction of the model is feasible using the Mckeague and Sasieni
(1994), whereby some coefﬁcients are time-invariant, and the Lin
and Ying (1994), whereby all coefﬁcients except the baseline are
kept time-invariant. This latter model is by analogy an additive
version of the Cox regression model. These methods are im-
plemented in the timereg package in R (Scheike & Martinussen,
2006). Standard tests (Scheike & Martinussen, 2006) for the time
dependence of coefﬁcients showed that they could be kept time-
invariant, thus, the coefﬁcients were presented as the additional
number of deaths per year per 1000 breast cancer patients.
Similarly, the cumulative baseline mortality could be seen to in-
crease linearly over time, and is therefore presented as the ex-
pected number of deaths per year per 1000 patients for the
reference group. Direct and indirect effect estimates as well as
effect estimates for the total effects were obtained by conducting a
parametric bootstrap resampling with 10,000 replications as de-
scribed by Nordahl et al. (2014).
To determine the plausibility of the results, a sensitivity ana-
lysis was conducted investigating education-speciﬁc changes in
incidence and by adjusting for the association between education
and the risk of dying from causes other than breast cancer. For the
analysis of incidence, Poisson regression modeling was used. The
population size data contained no information on civil status and
parity, as the population at risk was deﬁned as the aggregate po-
pulation stratiﬁed by education, year of diagnosis, age at diagnosis,
and year relative to the start of screening in each county. To ana-
lyze the association between education and the risk of dying from
causes other than breast cancer, all-cause mortality was compared
to cancer-related mortality (WHO ICDv10 C00-C97), breast-cancer
speciﬁc mortality (ICDv10 C50), and excess mortality by sub-
tracting the expected mortality by education level in the general
population. The data for the sensitivity analyses are discussed
in Appendix C.3. Results
3.1. Descriptive analyses
Descriptive statistics for the breast cancer patients included in
the study are presented in Table 2. Before the introduction of the
program, the group with a university level education had a higher
proportion of DCIS cancers and a lower proportion of late stage
cancers than did the groups with a secondary and primary school
education (data not shown). In the ﬁrst 2 years of the program,
there were relatively small differences between educational levels.
Thereafter, the distribution of cases in each stage across education
levels remained similar to that observed in the ﬁrst 2 years, but
with larger differences in the proportion of patients with DCIS and
advanced stage cancers between those with a primary school
education and those with a university education. In terms of age,
women with a primary school education were older (mean 61.1
years) than women with a secondary school education (mean 58.5
years) and women with a university education (57.2 years). Age of
Table 2
Descriptive statistics for breast cancer patients by level of education.
Variable Total Sample Primary school Secondary school University education
Before introduction 1862 (12%) 568 (14%) 939 (12%) 355 (10%)
Mean time before introduction (years) 1.6 (1.2) 1.6 (1.1) 1.6 (1.2) 1.7 (1.2)
After introduction 13,760 (88%) 3534 (86%) 6911 (88%) 3315 (90%)
0–2 years after 2352 (15%) 745 (18%) 1169 (15%) 438 (12%)
2-4 years after 2481 (16%) 679 (17%) 1281 (16%) 521 (14%)
4-6 years after 2962 (19%) 755 (18%) 1489 (19%) 718 (20%)
6-8 years after 2410 (15%) 592 (14%) 1231 (16%) 587 (16%)
8-12 years after 3555 (23%) 763 (19%) 1741 (22%) 1051 (29%)
Mean time after introduction (years) 5.0 (3.7) 4.5 (3.6) 5.0 (3.7) 5.6 (3.8)
Mean age at diagnosis 58.9 (5.6) 60.3 (5.6) 58.8 (5.5) 57.6 (5.4)
Mean year of diagnosis 2003.7 (2.8) 2003.4 (2.8) 2003.7 (2.8) 2004 (2.8)
Stage: DCIS 1955 (13%) 449 (11%) 996 (13%) 510 (14%)
Stage: TNM I 7683 (49%) 2051 (50%) 3872 (49%) 1760 (48%)
Stage: TNM II 5240 (34%) 1355 (33%) 2610 (33%) 1275 (35%)
Stage: TNM III/IV 744 (5%) 247 (6%) 372 (5%) 125 (3%)
Widow 1032 (7%) 378 (9%) 515 (7%) 139 (4%)
Married 10,052 (64%) 2579 (63%) 5204 (66%) 2269 (62%)
Divorced 2320 (15%) 629 (15%) 1132 (14%) 559 (15%)
Unmarried 2218 (14%) 516 (13%) 999 (13%) 703 (19%)
Parous 14,001 (90%) 3733 (91%) 7086 (90%) 3182 (87%)
Nulliparous 1621 (10%) 369 (9%) 764 (10%) 488 (13%)
Mortality rate per 1000 person-yearsa 23.2 (0.5) 29.5 (1.1) 22.0 (0.7) 17.0 (1.0)
Person-years during follow-up 83,318 22,226 41,905 19,187
Data are presented as a mean and standard deviation for continuous variables and the number and percentage of persons for categorical variables.
a Mortality rates are age standardized according to uniform weighting of age by age group: 50–54, 55–59, 60–64 and 65–69, where each age group contributes with
weight 0.25.
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Year of diagnosis differed less over time between education levels
and more according to time of program introduction (mean before
implementation: 2000; mean in the ﬁrst 2 years: 2002; mean after
2 years: 2004). Mortality rates decreased over time and by level of
attained education.
3.2. Within-education group changes in mortality at the introduc-
tion of screening
Table 3 shows the change in mortality at the introduction of the
NBCSP by education level. The total change in all-cause mortalityTable 3
Within-education group comparison of mortality rate differences per 1000 person-year
Variable Primary school Secon
Mortality rate Morta
Primary school
Secondary school
University education
Before [Ref.] [Ref.]
After (direct) 6.9 (15.0, 1.3) 0.2 (
After (indirect) 5.6 (6.7, 4.5) 2.5
After (total) 12.5 (20.6, 4.3) 2.3
Time after introduction (direct) 0.3 (1.3, 0.8) 0.2
Time after introduction (indirect) 0.2 (0.0, 0.4) 0.1 (
Time after introduction (total) 0.1 (1.0, 0.8) 0.2
Age (difference from 58.9) 0.9 (0.5, 1.3) 0.6 (0
Year (difference from July 2003) 1.3 (2.6, 0.1) 0.9
Widow [Ref.] [Ref.]
Married 2.8 (12.1, 6.4) 5.7
Divorced/separated 0.3 (11.1, 10.6) 4.6
Unmarried 10.5 (21.1, 0.1) 9.6
Parous [Ref.] [Ref.]
Nulliparous 13.4 (4.3, 22.5) 11.7 (
Baseline mortality rateb 35.7 (27.2, 44.2) 27.1 (
Numbers in parentheses are 95% conﬁdence intervals.
Separate regression models for each level of education.
a NBCSP: Norwegian Breast Cancer Screening Program.
b Cumulative baseline at 10.7 years follow-up converted into yearly rate.across periods was 12.5 deaths per 1000 person-years for those
with a primary school education [95% conﬁdence interval (CI):
20.6, 4.3], 2.3 deaths for those with a secondary school
education [CI: 6.8, 2.2, non-signiﬁcant (ns.)], and 4.5 deaths for
those with a university education [CI: 10.4, 1.4, ns.]. Deaths from
less severe cancer stages (the indirect effects) were reduced by
5.6 for those with a primary school education [CI: 6.7, 4.5],
2.5 deaths [CI: 3.0, 2.1] for those with a secondary school
education, and 1.4 deaths [CI: 0.9, 1.9] for those with a uni-
versity education. The overall reduction in mortality was 5.6
deaths [CI: 9.2, 2.1], and 3.1 [CI: 3.5, 2.7] due to less se-
vere cancers at diagnosis. None of the direct effects of programs at the introduction of the NBCSP.a
dary school University education Total Sample
lity rate Mortality rate Mortality rate
[Ref.]
7.1 (10.0, 4.3)
11.4 (14.5, 8.3)
[Ref.] [Ref.]
4.3, 4.7) 3.1 (9.1, 2.8) 2.5 (6.0, 1.0)
(3.0, 2.1) 1.4 (1.9, 0.9) 3.1 (3.5, 2.8)
(6.8, 2.2) 4.5 (10.4, 1.4) 5.6 (9.2, 2.1)
(0.9, 0.4) 0.0 (0.8, 0.7) 0.2 (0.6, 0.2)
0.0, 0.1) 0.0 (0.0, 0.1) 0.1 (0.0, 0.2)
(0.8, 0.4) 0.0 (0.7, 0.7) 0.1 (0.5, 0.3)
.4, 0.9) 0.5 (0.1, 0.8) 0.7 (0.5, 0.9)
(1.7, 0.2) 1.2 (2.2, 0.3) 1.1 (1.7, 0.6)
[Ref.] [Ref.]
(12.4, 1.1) 1.8 (12.5, 9.0) 4.3 (9.1, 0.6)
(12.4, 3.2) 2.8 (9.4, 15.0) 2.0 (7.6, 3.6)
(17.4, 1.7) 5.4 (16.6, 5.9) 9.0 (14.4, 3.6)
[Ref.] [Ref.]
6.0, 17.5) 9.5 (3.4, 15.6) 11.6 (7.7, 15.5)
21.1, 33.1) 19.5 (10.6, 28.3) 34.0 (29.5, 38.5)
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were the linear time trends after introduction.
3.3. Between-education group differences in mortality before and
after screening introduction
Table 4 shows the results of the analysis regarding the im-
portance of stage distribution before and after introduction of the
program. In the period before screening introduction, the total
difference in mortality was 13.8 deaths per 1000 person-years
[CI: 21.3, 6.3] for those with a secondary school education and
16 deaths [CI: 24.7, 7.3] for those with a university education
relative to the group with a primary school education. Before the
program, cancer stage at diagnosis mediated a difference in mor-
tality of 2.4 deaths [CI: 2.9, 2] for the group with a sec-
ondary school education relative to the group with a primary
school education. This difference was reduced at the introduction
of the program by 1.8 [CI: 1.3, 2.2], leading to a marginal rate
difference in the period of 0.7 [CI: 0.9, 0.5] in favor of the
group with a secondary school education. The mediated difference
between those with a primary school education and a university
education was 5 deaths [CI: 5.9, 4]. This difference was re-
duced by 3.2 deaths [CI; 2.2, 4.2] at introduction of the program.
The marginal rate difference due to stage of cancer was 1.8
deaths [CI: 2.2, 1.4] among the group with a universityTable 4
Between-education group comparison of mortality rate differences per 1000 person-ye
Variable
Before Primary school
Secondary school (direct)
Secondary school (indirect)
Secondary school (total)
University education (direct)
University education (indirect)
University education (total)
Before
After After
After X Secondary school (direct)
After X Secondary school (indirect)
After X Secondary school (total)
After X University education (direct)
After X University education (indirect)
After X University education (total)
Time after introduction (in years) Time after introduction (difference from 0)
Time after X Secondary school (direct)
Time after X Secondary school (indirect)
Time after X Secondary school (total)
Time after X University education (direct)
Time after X University education (indirect
Time after X University education (total)
Age (difference from 58.9)
Year (difference from July 2003)
Widow
Married
Divorced/separated
Unmarried
Parous
Nulliparous
Baseline mortality rateb
Numbers in parentheses are 95% conﬁdence intervals. Letters in superscript (a,b,c,d) outl
introduction.
Tests for interaction terms: X Education level (direct effects), p-value¼0.16. After X Edu
level (direct effects), p-value¼0.92. Time after introduction X Education level (indirect
a Norwegian Breast Cancer Screening Program.
b Cumulative baseline at 10.7 years follow-up converted into yearly rate.education after program introduction. Variables describing the
development of direct and indirect effects over time were negative
(indicative of increasing differences over time). The direct effects
over time were not signiﬁcant, however the interaction between
time after introduction and education level was signiﬁcant for the
indirect effects, p-value¼0.002. The total differences in mortality
after screening introduction were smaller than before, and the
group with a secondary education level had 4.4 deaths [CI: 9.4,
0.6, ns] while the group with a university education had 9.1
deaths [CI: 14.9, 3.4].
The main drivers of education-speciﬁc reductions and between
education differences were associated with levels of DCIS and
advanced stage cancers, which upon removal reduced the indirect
effects but remained signiﬁcant. No substantive differences were
noted in the analyses restricted to counties implementing the
program in the years 1999–2004 or in analyses that included
county as a covariate. Subdividing the time periods both before
[o1.5 and 41.5 years] and after [2 year periods: 0–2, 2–4, 4–6, 6–
8, 8–12] gave essentially the same results. Introducing a common
model for within-group differences led to the same conclusion.
The sensitivity analysis given in Table 5 in shows that the breast
cancer incidence increased more in both relative and absolute
terms for the group with a primary school education compared to
the group with a secondary school education or a university
education. The group with a secondary school education had aars before and after introduction of the NBCSP.a
Mortality rate per 1000 Marginal rate difference in period
[Ref.]
11.4 (18.9, 4.0) a1 ≡
2.4 (2.9, 2.0) b1 ≡
13.8 (21.3, 6.3) a1 þ b1 ≡
11.1 (19.7, 2.4) a2 ≡
5.0 (5.9, 4.1) b2 ≡
16.0 (24.8, 7.3) a2 þ b2 ≡
[Ref.]
11.8 (19.9, 3.9)
7.6 (1.3, 16.6) c1 3.7 (8.9, 1.4) a1 þ c1
1.8 (1.3, 2.2) d1 0.7 (0.9, 0.5) b1 þ d1
9.4 (0.2, 18.5) c1 þ d1 4.4 (9.4, 0.6) a1 þ c1 þ b1 þ d1
3.7 (6.6, 13.7) c2 7.3 (13.0, 1.7) a2 þ c2
3.2 (2.2, 4.2) d2 1.8 (2.2, 1.4) b2 þ d2
6.9 (3.5, 17.3) c2 þ d2 9.1 (14.9, 3.4) a2 þ c2 þ b2 þ d2
0.0 (0.8, 0.8)
0.2 (0.7, 0.3)
0.1 (0.1, 0.0)
0.2 (0.7, 0.3)
0.1 (0.8, 0.5)
) 0.0 (0.1, 0.1)
0.2 (0.8, 0.5)
0.7 (0.5, 0.8)
1.1 (1.6, 0.6)
[Ref.]
3.5 (7.9, 1.2)
1.3 (6.6, 3.9)
8.5 (13.7, 3.4)
[Ref.]
11.3 (7.4, 15.0)
37.8 (32.9, 42.7)
ine the calculations for total effects and the marginal rate differences after NBCSP
cation level (indirect effects), p-valueo0.001. Time after introduction X Education
effects), p-value¼0.002.
Table 5
Poisson regression model estimates for the incidence of breast cancer.
Variable Incidence rate ratios
Primary school [Ref.]
Secondary school 1.231 (1.106–1.370)
University education 1.446 (1.262–1.657)
Before [Ref.]
After 1.681 (1.513–1.867)
After X Secondary school a 0.862 (0.756–0.983)
After X University education a 0.779 (0.661–0.918)
Time after introduction (difference from 0) 0.997 (0.986–1.008)
Time after X Secondary school b 1.005 (0.992–1.018)
Time after X University education b 1.002 (0.987–1.018)
Age (difference from 58.9) 1.018 (1.015–1.021)
Year (difference from July 2003) 0.977 (0.970–0.985)
Baseline incidence per 100,000 PY 192 (175–210)
PY: person-years.
Numbers in parentheses are 95% conﬁdence intervals.
a Test for interaction: after X Education level, p-value 0.008.
b Test for interaction: time after introduction X Education level, p-value 0.767.
S.T. Klitkou / SSM -Population Health 2 (2016) 502–511 50723.1% higher incidence of breast cancer [CI: 10.6%, 37.0%] and the
group with university education had a 44.6% higher incidence [CI:
26.2%, 65.7%] relative to the group with a primary school educa-
tion, who had an incidence per 100,000 of 192 [CI: 175, 210] cases
at baseline before the introduction of the program. The incidence
surged in all three groups of education; however, the increase was
68.1% for the group with a primary school education, 58.7% for the
group with a secondary school education, and 53% for the group
with a university education. This corresponded to an absolute in-
crease of 131, 106, and 86 more cases per 100,000 person-years,
respectively.
The adjustment for the association between education and the
risk of dying from causes other than breast cancer is given in
Table 6. While increasing the speciﬁcity of mortality with regards
to cancer stage (as would be the case when considering deaths
that were either cancer-related or breast-cancer related or to the
excess mortality rate compared with the general population) had
little inﬂuence on the indirect effects of cancer stage it did inﬂu-
ence the direct effects across all education levels. For cancer-re-
lated and breast-cancer speciﬁc mortality, this means that the
mortality reduction associated with the introduction of the pro-
gram became more uniform across levels of education.Table 6
Between-education group comparison of all-cause, cancer-related, breast cancer, and ex
Variable All-cause Can
Primary school [Ref.] [Ref
Secondary school (direct) 11.4 (18.8, 3.9) 8
Secondary school (indirect) 2.4 (2.9, 2.0) 2
University education (direct) 11.1 (19.7, 2.4) 8
University education (indirect) 5.0 (5.9, 4.0) 4
Before [Ref.] [Ref
After 11.8 (19.8, 3.8) 10
After X Secondary school (direct) 7.6 (1.4, 16.6) 5.4
After X Secondary school (indirect) 1.8 (1.3, 2.2) 1.6
After X University education (direct) 3.7 (6.6, 14.1) 3.3
After X University education (indirect) 3.2 (2.2, 4.2) 2.9
Baseline mortality ratea 37.8 (32.9, 42.7) 32.5
Numbers in parentheses are 95% conﬁdence intervals.
All-cause analysis is provided for easy reference, and is the same model as in Table 4.
period.
a Cumulative baseline at 10.7 years follow-up converted into yearly rate.4. Discussion
The scope of this article was to study the role of cancer stage
and socioeconomic inequality in mortality. This study is inherently
limited in its focus given the complex relationship between SES
and breast cancer incidence and mortality in the general popula-
tion (Yabroff & Gordis, 2003). Indeed, the results are in line with a
central tenet of Yabroff and Gordis which stated that the re-
lationship between SES and mortality is dependent on the relation
of stage distribution with SES, which changes upon the introduc-
tion of a cancer control program.
The introduction of a public screening program was associated
with an increase in the incidence of breast cancer that, to some
degree, also had a leveling effect of incidence across education
levels. In my view, this is supportive of the main ﬁndings in this
study, since this suggests, but does not conﬁrm, that groups with
lower levels of attained education did indeed beneﬁt more from
the technology diffused by the introduction of the NBCSP. The
estimates of incidence increase are comparable to those of a recent
study investigating changes by cancer stage (Lousdal, Kristiansen,
Moller, & Stovring, 2016).
Since the cancer registry has almost complete coverage of
breast cancer incidence (Larsen et al., 2009), it follows that one can
also use the data source to evaluate cancer and breast-cancer
speciﬁc mortality as opposed to total mortality. When assessing
mortality among breast cancer patients, the results suggested that
direct differences (not through cancer stage) in mortality after the
introduction of the program were more uniform across education
levels, whereas the indirect effects (those through cancer stage)
remained similar to results observed in the all-cause analysis. One
interpretation of this ﬁnding, although not a deﬁnitive conclusion,
suggests that any previous differences in breast cancer mortality
(beyond what can be observed from the relationship between SES
and cancer stage) would remain in future investigations, but
would be more equal than differences found in analyses examin-
ing in all-cause mortality.
Cancer stage contributed to differences between socioeconomic
groups before screening began by an order of magnitude similar to
that found by Kravdal (2000). However, the ﬁgures are not directly
comparable owing to differences in time period, design, and focus
of the analysis. Nonetheless, previous studies have established a
link between cancer stage at diagnosis and SES (Lyratzopoulos
et al., 2012; Woods et al., 2006), and organized mammographycess mortality rate differences per 1000 person-years.
cer-related Breast cancer Excess mortality
.] [Ref.] [Ref.]
.2 (15.3, 1.0) 4.1 (10.2, 2.0) 6.1 (14.0, 1.9)
.3 (2.7, 1.8) 2.3 (2.7, 1.8) 2.5 (2.9, 2.0)
.5 (17.2, 0.2) 4.1 (11.8, 3.7) 2.8 (11.9, 6.5)
.6 (5.5, 3.7) 4.4 (5.3, 3.6) 5.0 (6.0, 4.1)
.] [Ref.] [Ref.]
.6 (18.2, 2.9) 8.3 (14.7, 1.8) 11.4 (20.0, 3.0)
(3.2, 14.0) 1.9 (5.7, 9.4) 7.4 (2.2, 17.0)
(1.2, 2.1) 1.6 (1.2, 2.1) 1.8 (1.3, 2.3)
(6.8, 13.5) 0.6 (8.5, 9.7) 3.1 (7.9, 14.0)
(1.9, 3.8) 2.8 (1.8, 3.7) 3.2 (2.2, 4.3)
(27.9, 37.0) 25.4 (21.4, 29.5) 29.5 (24.6, 34.4)
The table has been abbreviated, and shows the coefﬁcients of education and time
S.T. Klitkou / SSM -Population Health 2 (2016) 502–511508screening aims to diagnose the cancer at an earlier stage. For the
relationship between cancer stage and SES, the argument from the
current analysis is that the mammography screening had a level-
ing effect. In other words, the difference in mortality between
socioeconomic groups by cancer stage decreased after program
introduction.
The current study contrasts a previous study by Louwman et al.
(2007) investigating the impact of screening introduction on so-
cioeconomic variation in survival for a region in the Netherlands.
Comparing periods before (o1991), during, and after screening
introduction (41996) these authors found that while stage dis-
tribution improved for all socioeconomic groups, this improve-
ment favored the high status group in particular. Although noting
a SES–cancer stage relationship, these authors ultimately condi-
tioned on cancer stage in their multivariate analysis (cf. estimates
of direct effects as conceptualized in the current study). While
there are other important differences to Louwman et al. (2007),
this complicates an at least proximal comparison. However, their
results underscore the need for further studies on the impact of
screening on differences by SES. Indeed participation in the Dutch
screening program was higher among higher SES. While contrary
to the current results, the results by Louwman et al. need therefore
not be contrary to a technology diffusion process whereby the
higher SES are the ﬁrst to beneﬁt from new technology (Link et al.,
1998). For the Norwegian experience it seems that the current
study results ﬁt well with those of the pre-screening era, cf.
Kravdal (2000). However, it is a limitation of the current study
sample that the introduction for the Norwegian counties im-
plementing screening in 1995/1996 is not included to shed further
light on the historical development of the SES–cancer stage
relationship.
The current analysis showed that only a part of the reduction in
mortality that occurred after the introduction of screening can
reasonably be ascribed to changes occurring in stage distribution.
This indicates that many changes that inﬂuenced survival at the
introduction of screening were unrelated to changes in cancer
stage and may indeed be unrelated to screening. Furthermore, in
Norway, this difference in survival may also relate to reorganiza-
tion of treatment into multidisciplinary teams (Kalager et al.,
2009). As emphasized by Link et al. (1998), health differences by
SES might be inﬂuenced by the introduction and diffusion of new
technologies. However, the current analysis was unable to link
concurrent treatment changes in greater detail.
Furthermore, it is possible that unmeasured confounders ac-
count for the observed results. Although screening was introduced
at separate time points in Norwegian counties and that the ana-
lysis controlled for secular trends to mortality via calendar time,
the analysis lacks the existence of separate control group of
counties that did not introduce screening over the same time
period. This puts a limit on the ability to interpret the period effect
as the effect of screening introduction. Nevertheless, it should be
noted that any concurrent change should interfere primarily with
the indirect effects through cancer stage to affect the main con-
clusions of the current study.
The estimates of direct and indirect effects are themselves
subject to causal assumptions about the nature of the relationship
and the absence of confounding in a tripartite relationship, namely
that of screening introduction and cancer stage, screening in-
troduction and mortality, and cancer stage and mortality (Lange
et al., 2012). These relationships are all extended to also cover
education. This is, in all likelihood, a strong assumption, which in
addition to the assumption of absent causal factors between
education and cancer stage, and between screening introduction
and cancer stage, may contribute to overestimation due to residualconfounding. The estimation of mortality differences was aided by
comparing across different periods before and after screening in-
troduction. Screening introduction is therefore the exposure that
was intervened upon to change the effects of the mediator. It was
investigated whether screening introduction affected different
education groups differentially, and whether it reduced any pre-
existing difference between these groups. Screening introduction
was however not a randomized intervention in Norwegian coun-
ties, and so there may be confounding with both screening in-
troduction and education. At the outset, such confounding seems
likely since the counties implementing screening early were more
populous, more urban, and with higher levels of education. Com-
paring within each level of education therefore becomes im-
portant, since this arguably considers more homogenous groups
over time. The results from the analyses of within-education group
change and between-education group differences can thus be seen
as supportive of each other to the extent that they point towards
the same conclusion, even though the analyses themselves need
not be mutually exclusive. However, future studies should consider
other potential mediators of the effects of screening on cancer
stage.
The analysis also considered the introduction of the screening
program at the aggregate level and not whether the individual
woman actually underwent screening either before or after pro-
gram introduction. This repeated before-after design, with each
county introducing the program at different time-points, entails
an ecological intention-to-screen approach to the study of in-
dividual level data. An assumption of the analysis is, therefore, that
the difference in the proportion of women undergoing screening
and the associated increase in breast cancer incidence is mainly
driven by the onset of high participation rates.
Although the ﬁndings showed that the introduction of public
mammography screening diminished the contribution of stage
distribution on mortality differences related to SES, these ﬁndings
should be used carefully when advocating screening as a method
for cancer control in the population or as a method for reducing
socioeconomic inequalities in general. The present analysis is
limited and does not extend easily to other aspects of mammo-
graphy screening such as overdiagnosis. However, the analysis
raises important questions about the pursuit of equity and a public
screening program as a means to this end. Future studies on this
issue are needed to assess the generalizability of the current
ﬁndings.
In conclusion, the introduction of mammography screening had
implications for socioeconomic inequalities in mortality following
a breast cancer diagnosis. Although inequalities remained, the
introduction of public mammography screening reduced the im-
portance of cancer stage for differences in the mortality rate by
SES.Acknowledgment
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AVariable:Outcome Primary school Secondary school University education Overall
Log-odds (95% CI) Log-odds (95% CI) Log-odds (95% CI) Log-odds (95% CI)tercept:DCIS 0.73 (1.46, 0.01) 0.42 (0.98, 0.14) 1.19 (0.04, 2.34) 0.50 (0.92, 0.08)
tercept:TNM I 1.54 (0.98, 2.09) 1.51 (1.05, 1.97) 2.29 (1.22, 3.36) 1.46 (1.11, 1.80)
tercept:TNM II 1.34 (0.77, 1.91) 1.56 (1.09, 2.03) 2.25 (1.16, 3.34) 1.40 (1.05, 1.76)
fter:DCIS 1.05 (0.47, 1.62) 0.72 (0.28, 1.17) 0.12 (0.62, 0.86) 0.68 (0.37, 0.99)
fter:TNM I 0.38 (0.04, 0.80) 0.17 (0.18, 0.53) 0.13 (0.54, 0.79) 0.24 (0.01, 0.49)
fter:TNM II 0.07 (0.50, 0.36) 0.12 (0.48, 0.24) 0.19 (0.86, 0.48) 0.11 (0.36, 0.15)
ime after:DCIS 0.07 (0.01, 0.13) 0.09 (0.04, 0.13) 0.08 (0.01, 0.15) 0.08 (0.05, 0.11)
ime after:TNM I 0.06 (0.01, 0.12) 0.06 (0.02, 0.10) 0.05 (0.02, 0.12) 0.06 (0.03, 0.09)
ime after:TNM II 0.07 (0.01, 0.12) 0.03 (0.01, 0.08) 0.03 (0.03, 0.10) 0.04 (0.01, 0.07)
econdary school:DCIS 0.31 (0.11, 0.51)
econdary school:TNM I 0.20 (0.02, 0.37)
econdary school:TNM II 0.20 (0.02, 0.37)
niversity education:DCIS 0.66 (0.41, 0.92)
niversity education:TNM I 0.47 (0.24, 0.70)
niversity education:TNM II 0.53 (0.30, 0.77)
ge at diagnosis:DCIS 0.01 (0.04, 0.01) 0.03 (0.05, 0.01) 0.01 (0.04, 0.03) 0.02 (0.04, 0.00)
ge at diagnosis:TNM I 0.01 (0.02, 0.03) 0.01 (0.03, 0.01) 0.01 (0.02, 0.04) 0.00 (0.01, 0.01)
ge at diagnosis:TNM II 0.01 (0.03, 0.02) 0.03 (0.05, 0.01) 0.01 (0.04, 0.03) 0.02 (0.03, 0.00)
ear of diagnosis:DCIS 0.03 (0.10, 0.05) 0.03 (0.09, 0.03) 0.02 (0.11, 0.08) 0.03 (0.07, 0.01)
ear of diagnosis:TNM I 0.05 (0.11, 0.02) 0.01 (0.07, 0.04) 0.02 (0.10, 0.07) 0.03 (0.06, 0.01)
ear of diagnosis:TNM II 0.04 (0.11, 0.03) 0.02 (0.03, 0.07) 0.00 (0.08, 0.09) 0.00 (0.04, 0.04)
ulliparous:DCIS 0.36 (0.89, 0.18) 0.38 (0.77, 0.01) 0.56 (1.13, 0.01) 0.40 (0.67, 0.13)
ulliparous:TNM I 0.42 (0.86, 0.02) 0.51 (0.85, 0.17) 0.60 (1.13, 0.08) 0.50 (0.73, 0.26)
ulliparous:TNM II 0.45 (0.90, 0.00) 0.51 (0.86, 0.16) 0.75 (1.28, 0.21) 0.54 (0.79, 0.30)
arried:DCIS 0.21 (0.35, 0.76) 0.43 (0.00, 0.86) 0.35 (1.36, 0.65) 0.23 (0.09, 0.55)
arried:TNM I 0.03 (0.43, 0.48) 0.55 (0.18, 0.92) 0.05 (0.90, 1.00) 0.30 (0.03, 0.58)
arried:TNM II 0.21 (0.27, 0.68) 0.46 (0.08, 0.84) 0.06 (0.91, 1.03) 0.32 (0.04, 0.60)
ivorced/Separated:DCIS 0.25 (0.41, 0.92) 0.28 (0.23, 0.79) 0.35 (1.45, 0.76) 0.16 (0.21, 0.53)
ivorced/Separated:TNM I 0.06 (0.49, 0.62) 0.34 (0.10, 0.78) 0.06 (0.98, 1.10) 0.21 (0.12, 0.53)
ivorced/Separated:TNM II 0.19 (0.38, 0.77) 0.20 (0.25, 0.66) 0.24 (0.81, 1.30) 0.23 (0.10, 0.57)
nmarried:DCIS 0.05 (0.75, 0.65) 0.37 (0.19, 0.92) 0.13 (0.97, 1.23) 0.25 (0.14, 0.64)
nmarried:TNM I 0.15 (0.72, 0.42) 0.64 (0.16, 1.12) 0.26 (0.77, 1.30) 0.32 (0.02, 0.66)
nmarried:TNM II 0.21 (0.37, 0.80) 0.59 (0.10, 1.08) 0.49 (0.57, 1.54) 0.46 (0.11, 0.81)
eightsange (min, max) 0.43, 2.31 0.52, 1.90 0.81, 1.25 0.57, 1.76
st, 3rd quartile 0.88, 1.0 0.95, 1.0 0.89, 1.0 0.92, 1.0
.5%, 97.5% 0.45, 1.38 0.54, 1.28 0.86, 1.22 0.58, 1.30
ean (standard deviation) 1 (0.22) 1 (0.17) 1 (0.11) 1 (0.17)Reference outcome is TNM stage III/IV.Appendix B. Between-education group comparison. Multinomial logit for stage of cancer and resulting weightsVariable:Outcome Log-odds (95% CI) Weightstercept:DCIS 0.76 (1.32, 0.20) Range (min,max) 0.45, 2.20
tercept:TNM I 1.38 (0.97, 1.79) 1st, 3rd quartile 0.99, 1.01
tercept:TNM II 1.39 (0.98, 1.81) 2.5%, 97.5% 0.83, 1.11
econdary school:DCIS 0.51 (0.08, 1.10) Mean (standard deviation) 1 (0.08)
econdary school:TNM I 0.30 (0.11, 0.71)
econdary school:TNM II 0.20 (0.21, 0.61)
niversity education:DCIS 1.41 (0.65, 2.17)
niversity education:TNM I 0.65 (0.04, 1.27)
niversity education:TNM II 0.64 (0.02, 1.25)
fter:DCIS 1.05 (0.49, 1.61)
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fter:TNM II 0.13 (0.54, 0.29)
ime after:DCIS 0.07 (0.01, 0.12)
ime after:TNM I 0.05 (0.01, 0.10)
ime after:TNM II 0.05 (0.00, 0.10)
ge at diagnosis:DCIS 0.02 (0.04, 0.00)
ge at diagnosis:TNM I 0.00 (0.01, 0.01)
ge at diagnosis:TNM II 0.02 (0.03, 0.00)
ear of diagnosis:DCIS 0.03 (0.07, 0.01)
ear of diagnosis:TNM I 0.03 (0.06, 0.01)
ear of diagnosis:TNM II 0.00 (0.04, 0.04)
ulliparous:DCIS 0.40 (0.67, 0.12)
ulliparous:TNM I 0.50 (0.73, 0.26)
ulliparous:TNM II 0.54 (0.79, 0.30)
arried:DCIS 0.23 (0.09, 0.55)
arried:TNM I 0.30 (0.03, 0.58)
arried:TNM II 0.32 (0.04, 0.60)
ivorced/Separated:DCIS 0.16 (0.21, 0.54)
ivorced/Separated:TNM I 0.21 (0.12, 0.53)
ivorced/Separated:TNM II 0.23 (0.10, 0.57)
nmarried:DCIS 0.25 (0.14, 0.64)
nmarried:TNM I 0.32 (0.02, 0.66)
nmarried:TNM II 0.46 (0.11, 0.81)
econdary school X After:DCIS 0.32 (1.03, 0.38)
econdary school X After:TNM I 0.15 (0.68, 0.38)
econdary school X After:TNM II 0.04 (0.50, 0.58)
niversity education X After:DCIS 0.92 (1.84, 0.00)
niversity education X After:TNM I 0.21 (0.97, 0.56)
niversity education X After:TNM II 0.06 (0.84, 0.71)
econdary school X Time after:DCIS 0.02 (0.05, 0.08)
econdary school X Time after:TNM I 0.01 (0.05, 0.06)
econdary school X Time after:TNM II 0.01 (0.07, 0.05)
niversity education X Time after:DCIS 0.02 (0.06, 0.10)
niversity education X Time after:TNM I 0.00 (0.07, 0.07)
niversity education X Time after:TNM II 0.01 (0.08, 0.06)Reference outcome is TNM stage III/IV.Appendix C
Description 1. Aggregate statistical information on Norwegian women at the national and county level.1. Total person years on the national level by year, age, sex, and
education.
This data was input for analyses regarding the incidence of breast cancer and excess mortality. Incidence is the number of cases in a
category divided by person-years (total person-years minus the contribution of breast cancer person-years at follow-up).2. Number of deaths and person-years on the national level by
year, age, sex, and education.
This data was input for excess mortality. Excess mortality is the observed mortality rate in the patient population after subtracting the
expected mortality rate in the general population, where the general population is deﬁned in terms of year, age, sex, and level of education.3. County population size by year and education in the 50–59 and
60–66 year old age-groups (Statistics Norway, 2014b).
This data was input for the incidence of breast cancer by adjusting the person-year contribution by county speciﬁc education level.4. County speciﬁc population size by year, age, and sex (Statistics
Norway, 2014a).
This data was input for the incidence of breast cancer by disaggregating total person-years by county population size.
Description 2. Combining aggregate statistical information.
Enumerations of population size stratiﬁed by the county speciﬁc screening rounds.
The starting point for the current analysis was a dataset comprising the total Norwegian female population in person-time (years) and
number of deaths by age, year, sex, and education level.
It was not possible to distinguish between person-time before and after screening introduction, or subsequent screening rounds at the
national level, as this program was introduced at the county level. This is further complicated by counties introducing screening in
different years and having a different age- and year-speciﬁc population size as well as different levels of education.
S.T. Klitkou / SSM -Population Health 2 (2016) 502–511 511To supplement and extend the table on national person-time to reﬂect the introduction of screening at the county level, two aggregate
tables were extracted from Statistics Norway. One table contains the proportion of women with either a primary, secondary, or university
level education (Statistics Norway, 2014b) (i.e., the same classiﬁcation as applied in this study). This information was available by county
and stratiﬁed by year and age (50–59, 60–66, and more than 67 years old). The screening program targeted women aged 50–69. County-
speciﬁc proportions regarding the education level for women aged 67–69 were assigned the values of women aged 60–66, on the as-
sumption that this would be more reasonable than to assign ﬂat values for all women older than 67 years.
Another table from Statistics Norway contains population size by county, age, and year (Statistics Norway, 2014a).
The start of screening in each county was used as the ofﬁcial date of introduction in each county (Cancer Registry of Norway, 2014). The
date of screening introduction was combined with that dates for one round of screening (screening being performed biennially in Norway)
to construct the year-relative-to-screening introduction-speciﬁc person-time contribution. From the information on the date of screening
introduction the within-year contribution of person-time to the before–after design was calculated.
For the calculation of person-time to be distributed at the county level, the proportion of each year for each county belonging to each
period relative to screening start was computed. To classify person-time during the pre-program period, the date that screening started
(dd.mm.yyyy) minus date the year started (01.01.yyyy) divided by the total number of days in a year was calculated, on the assumption
that the proportion of person-time is constant within years. This equation equals the proportion of time within each year at the county
level before screening introduction, with the remainder belonging to the post-program period. This was, thereafter, repeated for any
subsequent screening round.
The ﬁnal table considered the year relative-to-screening introduction before and after screening as well as for subsequent screening rounds.
It also varied by the year- and age-speciﬁc proportion of patients with either a primary, secondary, or university level education in each county.ReferencesAalen, O. O. (1989). A linear regression model for the analysis of life times. Statistics
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